We further confirmed the highest therapeutic efficacy of the oncolytic virus that co-expresses HDAC1 shRNA and p73 in a mouse xenograft model by treating aggressively growing melanomas with a low virus dose of 3 × 108 PFU separated over three consecutive injections of 1 × 108 each. The gene discussed is HDAC1; the disease is melanoma.